Recipient-derived EBV-positive Monomorphic Plasmacytoma Type Posttransplant Lymphoproliferative Disorder After Allogeneic Stem Cell Transplant for Severe Aplastic Anemia: A Case Report.

TitleRecipient-derived EBV-positive Monomorphic Plasmacytoma Type Posttransplant Lymphoproliferative Disorder After Allogeneic Stem Cell Transplant for Severe Aplastic Anemia: A Case Report.
Publication TypeJournal Article
Year of Publication2016
AuthorsCarden MA, Caltharp S, Yee ME, Haight AE, Westblade LF, Park S
JournalJ Pediatr Hematol Oncol
Volume38
Issue8
Paginatione310-e314
Date Published2016 11
ISSN1536-3678
KeywordsAnemia, Aplastic, Child, Epstein-Barr Virus Infections, Fatal Outcome, Female, Graft Rejection, Hematopoietic Stem Cell Transplantation, Humans, Lung Diseases, Lymphoproliferative Disorders, Plasmacytoma, Transplantation, Homologous
Abstract

Monomorphic plasmacytoma-type posttransplant lymphoproliferative disorder (PTLD) has not been reported after pediatric hematopoietic stem cell transplantation. We present a child with hepatitis-associated severe aplastic anemia who underwent an unrelated allogeneic hematopoietic stem cell transplantation and subsequently developed graft failure and an Epstein-Barr virus-positive monomorphic plasmacytoma-type PTLD of recipient origin. Despite broad-spectrum antimicrobials, weaning immunosuppression, rituximab administration, and a stem cell boost she died from complications of PTLD and a fungal pulmonary infection on day +78.

DOI10.1097/MPH.0000000000000613
Alternate JournalJ Pediatr Hematol Oncol
PubMed ID27403771
Related Faculty: 
Lars Westblade, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700